Concepedia

Publication | Open Access

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

DOIFull Paper Access

2.4K

Citations

19

References

2020

Year

Aurélien Marabelle, Marwan Fakih, Juanita Lopez, Manisha H. Shah, Ronnie Shapira‐Frommer, Kazuhiko Nakagawa, Hyun Cheol Chung, Hedy L. Kindler, José A. López-Martín, Wilson H. Miller,
The Lancet Oncology

Abstract

Merck Sharp & Dohme Corp, a subsidiary of Merck & Co, Inc.

References

YearCitations

Page 1